Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Early gene expression changes with rush immunotherapy.

Davis LS, Bhutani S, Barnett SR, Khan DA.

Clin Mol Allergy. 2011 Sep 30;9:12. doi: 10.1186/1476-7961-9-12.

2.

Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis.

Nagao M, Hiraguchi Y, Hosoki K, Tokuda R, Usui T, Masuda S, Yamaguchi M, Fujisawa T.

Int Arch Allergy Immunol. 2008;146 Suppl 1:47-53. doi: 10.1159/000126061. Epub 2008 May 27.

PMID:
18504407
3.

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J.

Eur J Immunol. 1997 May;27(5):1131-9.

PMID:
9174602
4.

Decrease in CD23+ B lymphocytes and clinical outcome in asthmatic patients receiving specific rush immunotherapy.

Kljaic-Turkalj M, Cvoriscec B, Tudoric N, Stipic-Markovic A, Rabatic S, Trescec A, Gagro A, Dekaris D.

Int Arch Allergy Immunol. 1996 Oct;111(2):188-94.

PMID:
8859229
5.

Production of interleukin-12 by monocytes and interferon-gamma by natural killer cells in allergic patients during rush immunotherapy.

Plewako H, Wosińska K, Arvidsson M, Björkander J, Håkansson L, Rak S.

Ann Allergy Asthma Immunol. 2006 Oct;97(4):464-8.

PMID:
17069100
6.

Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9.

Tversky JR, Le TV, Bieneman AP, Chichester KL, Hamilton RG, Schroeder JT.

Clin Exp Allergy. 2008 May;38(5):781-8. doi: 10.1111/j.1365-2222.2008.02954.x. Epub 2008 Mar 1.

7.

Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy.

Plewako H, Wosińska K, Arvidsson M, Bjorkander J, Skov PS, Håkansson L, Rak S.

Int Arch Allergy Immunol. 2006;141(4):346-53. Epub 2006 Aug 29.

PMID:
16940746
8.
9.

Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma.

Reinero CR, Cohn LA, Delgado C, Spinka CM, Schooley EK, DeClue AE.

Vet Immunol Immunopathol. 2008 Feb 15;121(3-4):241-50. Epub 2007 Oct 2.

PMID:
17981343
10.
11.

Rush immunotherapy in an experimental model of feline allergic asthma.

Reinero CR, Byerly JR, Berghaus RD, Berghaus LJ, Schelegle ES, Hyde DM, Gershwin LJ.

Vet Immunol Immunopathol. 2006 Mar 15;110(1-2):141-53. Epub 2005 Dec 2.

PMID:
16325921
12.

Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.

Suárez-Fueyo A, Ramos T, Galán A, Jimeno L, Wurtzen PA, Marin A, de Frutos C, Blanco C, Carrera AC, Barber D, Varona R.

J Allergy Clin Immunol. 2014 Jan;133(1):130-8.e1-2. doi: 10.1016/j.jaci.2013.09.043. Epub 2013 Nov 28.

PMID:
24290282
13.

Allergen challenge of peripheral blood mononuclear cells from patients with seasonal allergic rhinitis increases IL-17RB, which regulates basophil apoptosis and degranulation.

Wang H, Mobini R, Fang Y, Barrenäs F, Zhang H, Xiang Z, Benson M.

Clin Exp Allergy. 2010 Aug;40(8):1194-202. doi: 10.1111/j.1365-2222.2010.03542.x. Epub 2010 Jun 7.

PMID:
20545698
14.

Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy.

Sørensen AE, Johnsen CR, Dalgaard LT, Würtzen PA, Kristensen B, Larsen MH, Ullum H, Søes-Petersen U, Hviid TV.

Int Arch Allergy Immunol. 2013;162(3):237-52. doi: 10.1159/000353281. Epub 2013 Sep 6.

PMID:
24022071
15.
16.

Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children.

Lou W, Wang C, Wang Y, Han D, Zhang L.

Pediatr Allergy Immunol. 2012 Mar;23(2):140-9. doi: 10.1111/j.1399-3038.2011.01249.x. Epub 2011 Dec 23.

PMID:
22192331
17.

Oral glucocorticoids diminish the efficacy of allergen-specific immunotherapy in experimental feline asthma.

Chang CH, Cohn LA, Declue AE, Liu H, Reinero CR.

Vet J. 2013 Aug;197(2):268-72. doi: 10.1016/j.tvjl.2013.01.008. Epub 2013 Feb 20.

PMID:
23434218
19.
20.

Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.

Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, Rossi O, Falagiani P, Riva G, Romagnani S, Annunziato F, Maggi E.

Clin Exp Allergy. 2006 Mar;36(3):261-72.

PMID:
16499636

Supplemental Content

Support Center